1Mori E ,Komori K,Kume M ,et al. Comparison of the long-term results between surgical and conservative treatment in patients with intermittent claudlcation. Surgery, 2002,131 : S269.
3Hsu SH , Chen WC. Improved cell adhesion by plasma-induced grafting of L-lactide onto surface. Biomaterials . 2000 ,21 (4).
4Nojirl C , Senshu K,Okano T. Nonthrombogenic polymer vascular prosthesis. Artlf Organs ,1995,19:32.
5Jeschke MG, Hermanutz V. Wolf SE, et al. Polyurethane vascular prostheses decrease neointimal formation compared with expanded polytetrafluoroethylene. J Vasc Surg. 1999, 29 (1)168.
6Weber N . Wendel HP, Ziemer G. Hemocompatibility of heparin-coated surfaces and the role of selectlve plasma protein adsorption. Biomaterials,2002,23 (2) : 429.
7Niu S, KurumataniH, Satoh S,et al. Small diameter vascular prostheses with incorporated bioabsorbablematrices. A preliminary study. ASAIO J,1993,39(3): M750.
8Kito H, Matsuda T. Biocompatible coatings for luminal and outer surfaces of small-caliber artificial grafts. J Biomed Mater Res, 1996, 30(3)- 321.
9Zilla P,Deutsch M,Meinhart J,et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts :an actuarial follow-up over three years. J Vascu Surg ,1994 ,19(3):540.
10Deutsch M,Meinhart J,Vesely M,et al. In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months. J Vasc Surg ,1997,25(4) :757.
